The 20 Best Pancreatectomy Doctors in Texas, US

Herbert Zeh Iii is a General Surgeon and an Oncologist practicing medicine in Dallas, Texas. Dr. Zeh Iii is rated as an Elite provider by MediFind in Pancreatectomy. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Ampullary Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

Ching-wei Tzeng is a General Surgeon practicing medicine in Houston, Texas. Dr. Tzeng is rated as an Elite provider by MediFind in Pancreatectomy. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Ductal Adenocarcinoma, Hepatectomy, and Pancreatectomy.

Michael Kim is a Surgical Oncologist practicing medicine in Houston, Texas. Dr. Kim is rated as an Elite provider by MediFind in Pancreatectomy. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

Naruhiko Ikoma is a Surgical Oncologist practicing medicine in Houston, Texas. Dr. Ikoma is rated as an Elite provider by MediFind in Pancreatectomy. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Stomach Cancer, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Gastrectomy, and Pancreaticoduodenectomy.

Dr Nicholas is a Transplant Surgeon practicing medicine in Dallas, Texas. Dr. Nicholas is rated as an Elite provider by MediFind in Pancreatectomy. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Chronic Pancreatitis, Hereditary Pancreatitis, Liver Failure, Islet Cell Transplantation, and Pancreatectomy.

Dr. Kimberly Washington is fellowship-trained in hepato-pancreato-biliary surgery with vast experience in the surgical and non-surgical treatment of liver, pancreas and biliary tract disorders. She uses a variety of techniques, including minimally invasive laparoscopy, endoscopy, ablation and robotic-assisted approaches, in the management of benign pancreatic masses, acute/chronic pancreatitis and pancreatic cysts. She is also trained in the management of hepatocellular carcinoma, cholangiocarcinoma and all liver metastatic diseases. Additionally, she treats benign diseases of the liver and biliary tract, including hepatic adenomas, liver hemangiomas, polycystic liver disease, simple and complex biliary stone disease, and bile duct injuries.Dr. Washington earned her medical degree and completed general surgery residency at the University of Tennessee in Memphis. She then served the Arlington, Texas community as a board-certified general surgeon from 2014 until 2020. In 2020, she returned to training in hepato-pancreato-biliary surgery fellowship at Oregon Health & Science University in Portland.In addition to her dedication to the management of surgical disease, Dr. Washington has also served on a global scale, caring for patients in India, Peru, Guatemala and Kenya. She has and continues to serve on numerous regional and national committees to advance the treatment of hepato-pancreato-biliary diseases. Dr Washington has published peer-reviewed works on areas of special interest, including multi-disciplinary management of colorectal liver metastasis with node-negative primary disease and surgical management of breast cancer liver metastasis, presenting many of these published works at national and international meetings. Through her role as a faculty member with the TCU Burnett School of Medicine, Dr. Washington was recognized in 2024 with the Gachman Endowed Faculty Excellence Award. She is a member of the American College of Surgeons, Americas Hepato-Pancreato-Biliary Association, American Pancreatic Association, Association of Women Surgeons, International Hepato-Pancreato-Biliary Association, Society of Surgical Oncology and Society for Surgery of the Alimentary Tract. Dr. Washington is rated as an Experienced provider by MediFind in Pancreatectomy. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatic Pseudocyst, Pancreatectomy, and Liver Embolization.

Dr. William E. Fisher is Professor and Vice-Chair for Clinical Affairs, Department of Surgery and the George L. Jordan, M.D. Chair in General Surgery at Baylor College of Medicine. Dr. Fisher also serves as Director of the Elkins Pancreas Center at BCM; and is Vice President, Medical Staff and Chief of the Surgery Service Line at Baylor St. Luke’s Medical Center.An internationally-known leader in pancreatic surgery, Dr. Fisher has focused entirely on surgery for pancreatic tumors and cysts in his practice for over 20 years and has extensive experience in advanced, minimally-invasive robotic pancreas surgery.Dr. Fisher’s professional interests include: pancreaticoduodenectomy (Whipple procedure); minimally invasive/laparoscopic/robotic pancreatic surgery; pancreas cancer; distal and central pancreatectomy; pancreas resection; surgical oncology; common bile duct resection; Puestow procedure; Frey procedure; and laparoscopic pancreatectomy.Dr. Fisher has served as PI of two NIH-funded multicenter randomized clinical trials that generated practice-changing impact on the use of drains during pancreatectomy, and the subsequent development of a multicenter pancreatic-surgery-outcomes consortium. His basic science lab has studied the influence of gastrointestinal hormones on pancreatic cancer growth, the relationship between diabetes and pancreatic cancer, and genomic analysis of pancreatic cancer, resulting in over 160 peer-reviewed publications.Having served as principal investigator on more than 15 clinical trials for patients with pancreatic cancer, Dr. Fisher is currently PI at BCM for the NIH Consortium to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer.Dr. Fisher received a B.A. from Wittenberg University and earned his medical degree from the University of Cincinnati College of Medicine.  He held a research fellowship and completed his residency at The Ohio State University.Among his numerous honors and awards, Dr. Fisher has been recognized as one of America’s Top Doctors for Cancer (Castle Connolly Medical Ltd.), Top 1% of Doctors in the U.S. (U.S. News and World Report), and “Texas Super Doctor” (Texas Monthly). He is also the recipient of the Master Clinician Award for Excellence in Patient Care from BCM and has twice received the DeBakey Distinguished Service Award from the Michael E. DeBakey Department of Surgery at BCM. Dr. Fisher is rated as a Distinguished provider by MediFind in Pancreatectomy. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Chronic Pancreatitis, Pancreatic Cancer, Hereditary Pancreatitis, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Fisher is currently accepting new patients.

Patricio Polanco is a Surgical Oncologist and a General Surgeon practicing medicine in Dallas, Texas. Dr. Polanco is rated as a Distinguished provider by MediFind in Pancreatectomy. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

Dhiresh Jeyarajah is a General Surgeon practicing medicine in Richardson, Texas. Dr. Jeyarajah is rated as a Distinguished provider by MediFind in Pancreatectomy. He is also highly rated in 63 other conditions, according to our data. His clinical expertise encompasses Hiatal Hernia, Hernia, Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Jeyarajah is board certified in - American Board Of Surgery/General Surgery, General Surgery- American Board Of Surgery/General Surgery, and General Surgery- American Board Of Surgery.

Dr. Tom Shires is a Fellow of the American College of Surgeons and sits on their Board of Governors. He specializes in hepatic, pancreatic and biliary surgery. He has followed in the footsteps of his surgeon father, who was a leading researcher and pioneer in the areas of trauma and burn care. Dr. Shires currently serves as the John P. Thompson Chair for Surgical Services at Texas Health Presbyterian Hospital Dallas and on the hospital's Board of Trustees. He also sits on numerous committees, including Texas Health Dallas' Medical Executive Committee and Surgical Services Committee.Dr. Shires graduated with honors from Duke University School of Medicine in Durham, N.C., and completed his general surgery residency training at Emory University School of Medicine in Atlanta, Ga. He was the Harvey Cushing Research Fellow at Cornell University Medical College New York Presbyterian Hospital and the Daniel Elkin Clinical Fellow at Emory.He has decades of experience in the use of advanced and minimally invasive surgical techniques. He previously served as Chief of Surgery at Zale-Lipshy University Hospital in Dallas and as Chairman of the GI and Endocrine Division at The University of Texas Southwestern Medical Center, also in Dallas. Dr. Shires is an avid lecturer, author, medical editor and medical reviewer. Dr. Shires' special interest in surgical education shows through in his role as the residency program director for surgery residents at Texas Health Dallas.Dr. Shires is an active member of such organizations as the North Texas Chapter of the American College of Surgeons, American Hepato Pancreato Biliary Association, The Society for Surgery of the Alimentary Tract, Surgical Infection Society and Association for Academic Surgery. Dr. Shires is rated as an Advanced provider by MediFind in Pancreatectomy. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Esophageal Cancer, Pancreatectomy, and Hernia Surgery.

Dr. Omar Barakat is a general surgeon specializing in benign and malignant diseases of the liver, bile duct, gallbladder, and pancreas. He is an Associate Professor of Surgery - Division of Surgical Oncology at Baylor College of Medicine and Medical Director of the Neuroendocrine Tumor Program at Baylor St. Luke’s Medical Center.Dr. Barakat’s clinical interests include: malignant hepatobiliary and pancreatic diseases, liver and pancreas surgery; upper gastrointestinal surgery; neuroendocrine tumors; gastrointestinal stromal tumors (GIST); and minimally invasive surgery.Dr. Barakat has developed new surgical techniques to minimize the complication rate and blood loss following pancreatic and liver surgeries. He utilizes image-guided therapies, such as radiofrequency ablation, microwave ablation, irreversible electroporation (NanoKnife system), trans-arterial chemotherapy, and selective internal radiotherapy (SIRT) with Yttrium-90 microspheres, to treat liver tumors while minimizing trauma to the patients. Dr. Barakat's clinical and research interests also include the study of neuroendocrine tumors; and the development of off-the-shelf bio-artificial liver organs that can be suitable for liver transplantation in patients with end-stage liver disease.Dr. Barakat received his medical degree from Aleppo University Medical School in Aleppo, Syria. He completed a residency in general surgery at the Medical College of Pennsylvania, Episcopal Hospital in Philadelphia and a Fellowship in cardiovascular surgery research at State University of New York - Buffalo. He also completed clinical fellowships in liver transplantation at The University of Texas Health Science Center in Houston; and in heart transplantation and mechanical assist devices aat the Texas Heart Institute. He continued his practice in liver and pancreatic surgery at Freeman Hospital in Newcastle Upon-Tyne, United Kingdom, where he treated complex and rare tumors of the liver, bile duct, and pancreas. Dr. Barakat is board-certified by the Royal College of Surgeons (Ed), United Kingdom, where he is also a Fellow. Dr. Barakat is rated as an Advanced provider by MediFind in Pancreatectomy. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Bile Duct Stricture, Chronic Pancreatitis, Gallbladder Disease, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Barakat is currently accepting new patients.

Suhail Sharif is a General Surgeon practicing medicine in Fort Worth, Texas. Dr. Sharif is rated as an Advanced provider by MediFind in Pancreatectomy. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Familial Pancreatic Cancer, Pancreatic Cancer, Familial Colorectal Cancer, Splenectomy, and Pancreatectomy. Dr. Sharif is board certified in General Surgery- American Board Of Surgery/General Surgery and General Surgery- American Board Of Surgery.

Dr. Testa is a Clinical Professor at Texas A&M College of Medicine at Texas A&M Health Science Center, Dallas. He is Chief of Abdominal Transplant at Baylor University Medical Center, part of Baylor Scott & White Health and Chairman of the Annette C. and Harold C. Simmons Transplant Institute. He specializes in living donor liver transplantation and is the principal investigator of the Uterine Transplant Clinical Trial that resulted in the first U.S. birth of a baby following uterine transplant. Dr. Testa was honored in 2018 as one of TIME Magazine's Top 100 for leading the medical team that performed the first successful uterus transplants in the nation. Dr. Testa is a graduate of t he University of Padova Medical School in Italy. After graduating cum laude, he completed a residency in general surgery at the same university. He went on to complete a general surgery residency at the University of Chicago and then a fellowship in abdominal organ transplant at Baylor University Medical Center in Dallas. Later at the University of Essen in Germany, he was instrumental in starting the first adult living donor liver transplant program in Europe. Dr. Testa returned to the U.S. in 2001, where he served as Director of Liver Transplant at the University of Illinois. In 2005, he moved to the University of Chicago where he rose to the rank of Professor of Surgery and served as Director of Liver Transplant and Hepatobilliary Surgery. Read more about Dr. Testa's publications on PubMed.gov and the Baylor Health Sciences Library. Dr. Testa returned to Baylor University Medical Center in 2011 to lead the Living Donor Liver Program. He became Chief of Abdominal Transplant for the Annette C. and Harold C. Simmons Transplant Institute in 2017. Dr. Testa is author or co-author of more than 160 publications and several book chapters. He is a recognized authority in Uterus Transplantation and Living Donor Liver Transplantation. His other interests include complex liver surgery of benign and malignant diseases. Read more about Dr. Testa Dr. Testa has been named one of Texas Monthly's Texas Super Doctors for over 10 years earning him a place on Texas Monthly's Hall of Fame list. Dr. Testa is rated as an Advanced provider by MediFind in Pancreatectomy. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Liver Failure, Hepatitis, Fibrolamellar Carcinoma, Liver Transplant, and Hysterectomy. Dr. Testa is board certified in Transplant Surgery- American Board Of Surgery/General Surgery and Transplant Surgery- American Board Of Surgery.

Scott Celinski is a Surgical Oncologist and a General Surgeon practicing medicine in Dallas, Texas. Dr. Celinski is rated as an Advanced provider by MediFind in Pancreatectomy. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatectomy, and Pancreaticoduodenectomy. Dr. Celinski is board certified in General Surgery- American Board Of Surgery/General Surgery, Surgical Critical Care- American Board Of Surgery/Surgical Critical Care, General Surgery- American Board Of Surgery, and Surgical Critical Care- American Board Of Surgery.

George Van Buren, II, M.D. is an associate professor of surgery in the Division of Surgical Oncology of the Michael E. DeBakey Department of Surgery at Baylor College of Medicine. Dr. Van Buren is a board-certified surgeon specializing surgical oncology and pancreatic disorders.A native Houstonian, Dr. Van Buren earned his undergraduate degree at the University of Texas at Austin and his medical degree at the University of Texas Medical School at Houston. He completed his general surgery residency at the University of Texas Medical School at Houston. During that time period, he spent two years at MD Anderson Cancer Center as an NIH T32 research fellow studying pancreatic cancer and neuroendocrine tumors. He completed his surgical oncology fellowship at the University of Pittsburgh Medical Center in the Translational Pancreas Research Track.During Dr. Van Buren’s research and clinical fellowships, he was able to expand upon his interest in gastrointestinal surgical oncology and pancreatic disorders. Specifically, his training had a heavy emphasis on pancreatic and gastric malignancies with exposure to wide breadth of cases, including specialized procedures such as robotic pancreatic surgery.Dr. Van Buren is active in both patient care and research. He has spent over 15 years in training and in practice focusing on care for patients with pancreatic and gastrointestinal malignancies. He is involved in both basic science and clinical research and believes heavily in the surgeon’s role as a leader of the translational research team. His goals are to provide high quality clinical care while offering his patients access to innovative clinical and therapeutic trials. He is a member of the Elkins Pancreas Center and Dan L. Duncan NCI Cancer Center at Baylor College of Medicine. Dr. Van Buren is rated as an Advanced provider by MediFind in Pancreatectomy. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Gallbladder Cancer, Gallbladder Adenocarcinoma, Splenectomy, and Pancreatectomy. Dr. Van Buren is currently accepting new patients.

David Smith is a Surgical Oncologist practicing medicine in Tyler, Texas. Dr. Smith is rated as an Advanced provider by MediFind in Pancreatectomy. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Congenital Diaphragmatic Hernia, Small Bowel Resection, and Pancreatectomy. Dr. Smith is board certified in American Board Of Surgery.

Jeffrey Lamont is a General Surgeon and a Surgical Oncologist practicing medicine in Plano, Texas. Dr. Lamont is rated as an Advanced provider by MediFind in Pancreatectomy. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Familial Pancreatic Cancer, Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection. Dr. Lamont is board certified in General Surgery- American Board Of Surgery/General Surgery and General Surgery- American Board Of Surgery.

Thomas Aloia is a Surgical Oncologist practicing medicine in Houston, Texas. Dr. Aloia is rated as a Distinguished provider by MediFind in Pancreatectomy. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Gallbladder Adenocarcinoma, Hepatectomy, and Hepato-Pancreato-Biliary Surgery.

Alexander Parikh is a General Surgeon practicing medicine in San Antonio, Texas. Dr. Parikh is rated as a Distinguished provider by MediFind in Pancreatectomy. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Stomach Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

Zehra Tekin is an Endocrinologist practicing medicine in Canton, Texas. Dr. Tekin is rated as an Advanced provider by MediFind in Pancreatectomy. She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Idiopathic Hypercalciuria, Milk-Alkali Syndrome, Familial Hypocalciuric Hypercalcemia Type 1, Pancreatectomy, and Islet Cell Transplantation.